Clinical utility and prospective of TMS-EEG.

Biomarker Clinical populations Electroencephalography (EEG) TMS–EEG Transcranial magnetic stimulation (TMS) Treatment

Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
05 2019
Historique:
received: 13 07 2018
revised: 07 01 2019
accepted: 08 01 2019
pubmed: 18 2 2019
medline: 18 2 2020
entrez: 18 2 2019
Statut: ppublish

Résumé

Concurrent transcranial magnetic stimulation and electroencephalography (TMS-EEG) has emerged as a powerful tool to non-invasively probe brain circuits in humans, allowing for the assessment of several cortical properties such as excitability and connectivity. Over the past decade, this technique has been applied to various clinical populations, enabling the characterization and development of potential TMS-EEG predictors and markers of treatments and of the pathophysiology of brain disorders. The objective of this article is to present a comprehensive review of studies that have used TMS-EEG in clinical populations and to discuss potential clinical applications. To provide a technical and theoretical framework, we first give an overview of TMS-EEG methodology and discuss the current state of knowledge regarding the use of TMS-EEG to assess excitability, inhibition, plasticity and connectivity following neuromodulatory techniques in the healthy brain. We then review the insights afforded by TMS-EEG into the pathophysiology and predictors of treatment response in psychiatric and neurological conditions, before presenting recommendations for how to address some of the salient challenges faced in clinical TMS-EEG research. Finally, we conclude by presenting future directions in line with the tremendous potential of TMS-EEG as a clinical tool.

Identifiants

pubmed: 30772238
pii: S1388-2457(19)30001-X
doi: 10.1016/j.clinph.2019.01.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

802-844

Subventions

Organisme : Medical Research Council
ID : MR/K013998/1
Pays : United Kingdom
Organisme : CIHR
Pays : Canada

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Auteurs

Sara Tremblay (S)

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Royal Ottawa Institute of Mental Health Research, Ottawa, ON, Canada. Electronic address: sara.tremblay@theroyal.ca.

Nigel C Rogasch (NC)

Brain and Mental Health Research Hub, School of Psychological Sciences, Monash Institute of Cognitive and Clinical Neuroscience, and Monash Biomedical Imaging, Monash University, Australia.

Isabella Premoli (I)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.

Daniel M Blumberger (DM)

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Silvia Casarotto (S)

Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy.

Robert Chen (R)

Krembil Research Institute, University Health Network and Division of Neurology, Department of Medicine, University of Toronto, Canada.

Vincenzo Di Lazzaro (V)

Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine, Università Campus Bio-Medico di Roma, via Álvaro del Portillo 21, 00128 Rome, Italy.

Faranak Farzan (F)

Simon Fraser University, School of Mechatronic Systems Engineering, B.C., Canada.

Fabio Ferrarelli (F)

Department of Psychiatry, University of Pittsburgh, PA, USA.

Paul B Fitzgerald (PB)

Epworth Healthcare, The Epworth Clinic, Camberwell, Victoria, Australia; Monash Alfred Psychiatry Research Centre, The Alfred and Monash University Central Clinical School, Victoria, Australia.

Jeanette Hui (J)

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Risto J Ilmoniemi (RJ)

Department of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.

Vasilios K Kimiskidis (VK)

Laboratory of Clinical Neurophysiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.

Dimitris Kugiumtzis (D)

Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.

Pantelis Lioumis (P)

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Alvaro Pascual-Leone (A)

Berenson-Allen Center for Noninvasive Brain Stimulation and Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, MA 02215, USA.

Maria Concetta Pellicciari (MC)

Non-invasive Brain Stimulation Unit, Department of Behavioral and Clinical Neurology, Santa Lucia Foundation IRCCS, Rome, Italy.

Tarek Rajji (T)

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Gregor Thut (G)

Centre for Cognitive Neuroimaging, Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK.

Reza Zomorrodi (R)

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Ulf Ziemann (U)

Department of Neurology & Stroke, and Hertie Institute for Clinical Brain Research, University of Tübingen, Germany.

Zafiris J Daskalakis (ZJ)

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH